A recent analysis by the Associated Press found that despite continuing price increases for brand-name prescription drugs, the pace of increases has slowed and the amount of each price hike is less significant.
AP used drug pricing data provided by Elsevier.
According to the report, drug makers in the first seven months of 2019 raised prices by a median of 5 percent, down from 9 to 10 percent from the previous four years. There were a total of 4,483 price increases during the same period, which is a whopping 36 percent dip from 2015.
“This rhetoric around drug prices may be starting to bend the curve, but we’re not getting to the point of actual decreases in the total cost of drugs,” Dartmouth Institute for Health Policy and Clinical Practice’s Adrienne Faerber said. “Very few drug prices go down.”
To read the full report on the Associated Press, click here.